Total planned funding: $256,454,367
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $51,450,277 |
Nigeria | $38,162,254 |
Zambia | $27,076,466 |
Kenya | $21,575,956 |
South Africa | $18,112,198 |
Namibia | $8,125,914 |
India | $7,814,357 |
Rwanda | $7,679,975 |
Vietnam | $6,841,375 |
Guyana | $6,620,000 |
Ethiopia | $6,526,111 |
Tanzania | $6,150,000 |
Côte d'Ivoire | $5,755,736 |
Haiti | $4,988,452 |
Indonesia | $4,976,794 |
Burundi | $4,608,504 |
Zimbabwe | $4,344,201 |
Asia Regional Program | $3,400,093 |
Democratic Republic of the Congo | $3,390,975 |
Malawi | $2,701,446 |
Caribbean Region | $2,525,420 |
Papua New Guinea | $2,486,306 |
Angola | $2,466,719 |
Eswatini | $2,047,187 |
Cambodia | $2,025,000 |
Uganda | $1,945,686 |
Botswana | $1,840,003 |
South Sudan | $566,962 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $256,454,367 |
Program Areas
Treatment | $47,528,537 |
Care | $42,099,178 |
Prevention | $34,023,569 |
Testing | $16,986,131 |
Governance and Systems | $12,441,871 |
Budget Codes
HTXS: Treatment: Adult Treatment | $43,208,444 |
HVOP: Sexual Prevention: Other Sexual Prevention | $25,765,491 |
HKID: Care: Orphans and Vulnerable Children | $24,580,398 |
HVCT: Testing: HIV Testing and Counseling | $16,986,131 |
HBHC: Care: Adult Care and Support | $10,640,346 |
OHSS: Health Systems Strengthening | $5,307,780 |
HVSI: Strategic Information | $5,014,987 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,577,043 |
PDCS: Care: Pediatric Care and Support | $4,480,222 |
PDTX: Treatment: Pediatric Treatment | $4,320,093 |
HVTB: Care: TB/HIV | $2,398,212 |
HLAB: Laboratory Infrastructure | $2,119,104 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,093,360 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $842,969 |
HMBL: Biomedical Prevention: Blood Safety | $334,929 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $232,093 |
HMIN: Biomedical Prevention: Injection Safety | $177,684 |
HTXD: Treatment: ARV Drugs | $0 |